How can astronauts stay safe when life-support systems are aging and data monitoring is fragmented? A recent NASA audit has reignited discussion about space health research. It focuses on one of the most vital systems keeping…
This Halloween, we made sure language barriers don’t haunt clinical research. 👻 We’re proud to facilitate more inclusive clinical trials by helping top sponsors and study teams communicate with participants in multiple languages—equipping them with the tools to reach the…
TrialX, in collaboration with investigators at the University of Iowa is proud to announce that the SAYSTOP Study App, developed to study antibiotic resistance using our remote data collection solution, has successfully completed enrollment. The “Study of…
Imagine a world where studying cancer in space could help unlock new treatments on Earth. The Cancer in LEO-3 experiment aboard Axiom Mission 4 (Ax-4) investigated triple-negative breast cancer organoids to understand how microgravity affects tumor…
The 15th annual DPHARM: Disruptive Innovations to Modernize Clinical Research (September 16–17, 2025, Philadelphia, PA) brought together senior clinical operations executives, patient advocates, and technology leaders to explore the future of clinical trials. AI, patient-centric trial…
What happens to the human body when gravity disappears? Astronauts experience rapid cardiovascular and vestibular adaptation, which can cause dizziness, fainting, or impaired performance. The Ax-4 mission’s Telemetric Health AI (TESH) study captures these physiological changes…
🏈 Kicking Off Progress in ALS Research – We’re honored to share that TrialX’s global clinical trial finder now powers the ALS Network’s Trial Finder—an AI-driven platform designed to help individuals easily discover clinical trials focused on amyotrophic…
